Apyx Medical (APYX) Receivables - Net (2010 - 2026)

Apyx Medical has reported Receivables - Net for 17 years, with the latest figure at $12.8 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 9.53% year-over-year to $12.8 million; the trailing twelve-month figure through Mar 2026 stood at $12.8 million (up 9.53% YoY), and the FY2025 full-year result was $16.8 million, up 8.37% from the prior year.
• Receivables - Net for Q1 2026 stood at $12.8 million, down from $16.8 million in the prior quarter.
• The five-year high for Receivables - Net was $16.8 million in Q4 2025, with the low at $9.1 million in Q3 2022.
• Historically, Receivables - Net has averaged $12.4 million across 5 years, with a median of $12.5 million in 2024.
• The largest YoY upside for Receivables - Net was 60.91% in 2022 against a maximum downside of 20.53% in 2022.
• Apyx Medical's Receivables - Net stood at $10.6 million in 2022, then soared by 32.27% to $14.0 million in 2023, then grew by 10.39% to $15.5 million in 2024, then climbed by 8.37% to $16.8 million in 2025, then slipped by 23.97% to $12.8 million in 2026.
• The last three Receivables - Net figures came in at $12.8 million (Q1 2026), $16.8 million (Q4 2025), and $13.0 million (Q3 2025), per Business Quant data.